Bhagiradha Chemicals & Industries Limited — Important, 19-02-2025: Updates

**Financial Highlights**: For the quarter and nine months ended December 31, 2024, Bhagiradha Chemicals presented a revenue of ₹317.9 Cr, up 7% YoY, despite subdued pricing impacting sales realisations. EBITDA mirrored sales growth, reaching ₹30.9 Cr with a margin of 9.7%. Profit After Tax (PAT) surged by 34% to ₹14.7 Cr, aided by higher other income from warrant conversions.

**Strategic Initiatives and Growth Drivers**: The company is progressing on a ₹800 Cr capex plan, with an initial phase of ~₹385 Cr to enhance capacity, aiming for impactful operational phases by mid-2025. New product launches in insecticides and fungicides strengthen their market position.

**Business Developments**: Revenue recovery and volume growth are encouraging, with management noting a positive shift in demand and the potential for price stabilization. Ongoing capex plans and product expansion are set to bolster future performance.

**Market Position and Competitive Advantage**: Bhagiradha continues to build on its strong R&D profile, positioning itself competitively against international players, especially amidst pricing pressures from Chinese market oversupply.

**Investor Implications**: A positive outlook driven by recovery in volumes and strategic future initiatives underscores Bhagiradha’s potential for growth. Investors should watch developments closely, particularly the anticipated growth from new products and facility expansions.